NASDAQ:MRNS
Marinus Pharmaceuticals, Inc.
- Stock
Last Close
1.33
16/05 20:00
Market Cap
546.83M
Beta: 1.16
Volume Today
918.17K
Avg: 544.92K
PE Ratio
−4.02
PFCF: −4.81
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -3.14M - | -7.80M 148.12% | -4.62M 40.80% | 1.25M 126.97% | ||||||||
average payables | 96.42K - | 306.89K 218.27% | 1.84M 499.89% | 2.98M 61.73% | 1.87M 37.26% | 1.70M 9.02% | 2.62M 54.02% | 2.49M 4.99% | 2.67M 7.30% | 4.73M 77.38% | 5.17M 9.26% | |
average receivables | 823K - | 2.42M 193.56% | 4.77M 97.31% | 5.07M 6.43% | ||||||||
book value per share | 4.69 - | 26.76 470.25% | 12.58 52.98% | 4.41 64.97% | 9.86 123.69% | 6.68 32.20% | 6.44 3.63% | 5.03 21.88% | 1.46 71.03% | 2.97 103.69% | 0.00 99.99% | |
capex per share | -0.01 - | -0.02 152.63% | -0.09 339.88% | -0.13 39.99% | -0.08 42.12% | -0.01 89.38% | -0.03 250.70% | -0.08 - | -0.05 42.33% | -0.00 100.00% | ||
capex to depreciation | -1.75 - | -6.60 277.44% | -32 384.85% | -28 12.50% | -3.57 87.24% | -0.65 81.70% | -1.40 113.56% | -8.14 - | -4.24 47.85% | 0.15 103.50% | ||
capex to operating cash flow | 0.00 - | 0.00 48.76% | 0.02 355.14% | 0.03 48.68% | 0.02 8.02% | 0.00 87.53% | 0.01 167.62% | 0.05 - | 0.02 69.82% | 0.00 93.58% | ||
capex to revenue | -0.19 - | -0.07 63.02% | -0.00 94.48% | |||||||||
cash per share | 4.98 - | 32.32 549.20% | 15.07 53.39% | 6.17 59.01% | 9.07 46.92% | 7.11 21.59% | 6.73 5.42% | 5.13 23.70% | 3.35 34.74% | 6.16 83.79% | 0.00 99.95% | |
days of inventory on hand | -2.30K - | 82.66 103.60% | 461.36 458.14% | |||||||||
days payables outstanding | 771.98 - | 6.81K 781.79% | 765.37 88.76% | |||||||||
days sales outstanding | 349.70 - | 75.78 78.33% | 90.94 20.00% | 44.75 50.80% | ||||||||
debt to assets | 0.14 - | 0.12 11.29% | 0.17 34.82% | 0.00 - | 0.00 24.88% | 0.30 8,818.19% | 0.28 7.36% | 0.43 52.47% | ||||
debt to equity | 0.17 - | 0.16 7.55% | 0.24 55.24% | 0.01 - | 0.00 26.85% | 0.77 20,705.29% | 0.63 18.99% | 4.35 594.76% | ||||
dividend yield | ||||||||||||
earnings yield | -0.08 - | -0.17 103.90% | -0.22 30.88% | -1.45 567.17% | -0.10 93.24% | -0.31 218.06% | -0.46 45.93% | -0.20 56.13% | -0.23 16.41% | -0.13 45.35% | -0.00 99.81% | |
enterprise value | 54.47M - | 22.31M 59.04% | 69.64M 212.11% | -1.24M 101.78% | 158.56M 12,867.87% | 49.64M 68.69% | 27.25M 45.11% | 194.70M 614.46% | 353.84M 81.74% | -12.37M 103.50% | 584.18B 4,723,754.96% | |
enterprise value over ebitda | -10.54 - | -2.08 80.23% | -2.86 37.21% | 0.04 101.54% | -8.46 19,284.16% | -1.36 83.97% | -0.50 62.89% | -2.87 469.41% | -3.68 28.36% | 2.15 158.42% | -4.44K 206,850.84% | |
ev to operating cash flow | -8.22 - | -2.60 68.39% | -3.46 33.18% | 0.05 101.45% | -8.43 16,907.36% | -1.78 78.84% | -0.56 68.57% | -3.20 470.44% | -6.38 99.55% | 0.11 101.72% | -4.95K 4,518,998.26% | |
ev to sales | 113.33 - | 23.06 79.65% | -0.49 102.11% | 18.85K 3,883,712.93% | ||||||||
free cash flow per share | -3.30 - | -5.61 70.04% | -5.49 2.04% | -5.21 5.05% | -3.27 37.21% | -2.73 16.57% | -3.60 31.69% | -2.23 37.90% | -1.59 28.79% | -2.93 84.51% | -0.00 99.93% | |
free cash flow yield | -0.10 - | -0.13 28.70% | -0.18 35.53% | -1.29 618.20% | -0.10 92.23% | -0.24 137.22% | -0.42 74.98% | -0.18 56.02% | -0.13 26.88% | -0.74 450.74% | -0.00 99.97% | |
graham net net | 3.81 - | 26.43 594.65% | 11.65 55.93% | 4.13 64.55% | 8.62 108.71% | 6.44 25.32% | 5.91 8.12% | 4.58 22.62% | 1.02 77.79% | 2.61 156.35% | 0.00 100.00% | |
graham number | 16.61 - | 65.11 291.95% | 43.42 33.31% | 24.14 44.42% | 26.69 10.56% | 23.24 12.91% | 23.91 2.88% | 16.63 30.44% | 9.53 42.69% | 5.82 38.93% | 0.00 99.93% | |
income quality | 1.26 - | 0.79 36.96% | 0.81 2.16% | 0.86 6.76% | 1.00 15.14% | 0.76 23.86% | 0.90 18.53% | 0.90 0.46% | 0.56 37.78% | 5.70 914.29% | 0.83 85.35% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -59.36 - | -101.88 71.63% | -51.44 49.51% | -60.87 18.33% | -119.77 96.77% | -37.54 - | -10.57 71.85% | 7.78 173.64% | ||||
interest debt per share | 0.04 - | 4.63 10,193.75% | 2.11 54.50% | 1.17 44.39% | 0.03 97.69% | 0.03 - | 0.02 42.85% | 1.20 6,303.43% | 2.13 78.12% | 0.00 99.95% | ||
inventory turnover | -0.16 - | 4.42 2,880.80% | 0.79 82.08% | |||||||||
invested capital | 0.17 - | 0.16 7.55% | 0.24 55.24% | 0.01 - | 0.00 26.85% | 0.77 20,705.29% | 0.63 18.99% | 4.35 594.76% | ||||
market cap | 64.51M - | 65.03M 0.82% | 113.99M 75.27% | 19.69M 82.72% | 192.09M 875.43% | 117.37M 38.90% | 117.75M 0.32% | 332.69M 182.55% | 435.96M 31.04% | 155.51M 64.33% | 584.22B 375,585.56% | |
net current asset value | 9.43M - | 41.09M 335.60% | 45.03M 9.58% | 20.33M 54.85% | 30.87M 51.82% | 67.03M 117.16% | 83.06M 23.91% | 126.89M 52.77% | 39.57M 68.81% | 97.03M 145.20% | 11.10M 88.56% | |
net debt to ebitda | 1.94 - | 3.99 105.42% | 1.82 54.37% | 0.74 59.15% | 1.79 140.66% | 1.85 3.42% | 1.67 9.68% | 2.03 21.53% | 0.85 57.97% | 29.17 3,317.06% | 0.36 98.76% | |
net income per share | -2.61 - | -7.04 169.41% | -6.66 5.40% | -5.88 11.80% | -3.21 45.35% | -3.59 11.87% | -3.95 9.83% | -2.44 38.06% | -2.77 13.36% | -0.51 81.69% | -0.00 99.47% | |
operating cash flow per share | -3.29 - | -5.58 69.83% | -5.40 3.35% | -5.08 5.84% | -3.20 37.08% | -2.72 14.82% | -3.57 31.04% | -2.23 37.41% | -1.51 32.32% | -2.89 91.11% | -0.00 99.92% | |
payables turnover | 0.47 - | 0.05 88.66% | 0.48 789.40% | |||||||||
receivables turnover | 1.04 - | 4.82 361.45% | 4.01 16.67% | 8.16 103.24% | ||||||||
research and ddevelopement to revenue | 29.75 - | 4.79 83.89% | 3.14 34.54% | 3.21 2.25% | ||||||||
return on tangible assets | -0.45 - | -0.22 51.59% | -0.42 93.06% | -0.91 118.68% | -0.31 65.80% | -0.49 56.72% | -0.54 11.43% | -0.44 18.58% | -0.74 67.73% | -0.08 89.72% | -0.85 1,007.13% | |
revenue per share | 0.06 - | 0.42 563.74% | 0.65 55.94% | 0.00 99.91% | ||||||||
roe | -0.56 - | -0.26 52.76% | -0.53 101.20% | -1.33 151.79% | -0.33 75.57% | -0.54 64.99% | -0.61 13.97% | -0.49 20.71% | -1.90 291.30% | -0.17 91.01% | -8.62 4,944.86% | |
roic | -0.57 - | -0.28 50.95% | -0.46 65.23% | -1.07 133.76% | -0.33 69.34% | -0.55 67.69% | -0.61 10.70% | -0.49 20.39% | -1.02 111.02% | -0.71 30.34% | -1.48 107.52% | |
sales general and administrative to revenue | 10.80 - | 2.43 77.50% | ||||||||||
shareholders equity per share | 4.69 - | 26.76 470.25% | 12.58 52.98% | 4.41 64.97% | 9.86 123.69% | 6.68 32.20% | 6.44 3.63% | 5.03 21.88% | 1.46 71.03% | 2.97 103.69% | 0.00 99.99% | |
stock based compensation to revenue | 4.45 - | 0.90 79.68% | 0.58 35.33% | 0.50 14.07% | ||||||||
tangible asset value | 9.46M - | 41.15M 335.12% | 46.92M 14.01% | 21.48M 54.22% | 58.01M 170.07% | 68.33M 17.79% | 87.77M 28.46% | 137.20M 56.32% | 53.49M 61.02% | 116M 116.88% | 16.77M 85.55% | |
tangible book value per share | 4.69 - | 26.76 470.25% | 12.58 52.98% | 4.41 64.97% | 9.86 123.69% | 6.68 32.20% | 6.44 3.63% | 5.03 21.88% | 1.46 71.03% | 2.97 103.69% | 0.00 99.99% | |
working capital | 9.43M - | 48.11M 410.02% | 50.33M 4.62% | 22.21M 55.86% | 30.99M 39.49% | 67.03M 116.32% | 86.10M 28.45% | 129.43M 50.32% | 82.36M 36.36% | 185.68M 125.44% | 124.62M 32.88% |
All numbers in USD (except ratios and percentages)